Research
Hormonal
High dietary protein intake is not detrimental to bone health and may support bone microarchitecture and strength, particularly from animal and dairy sources.
You do not need to limit protein for the sake of your bones. High protein intake, especially from dairy and animal sources, is associated with stronger bone structure. Ensure adequate calcium and vitamin D, but do not fear protein.
ModerateQualifiesMEDIUM confidence
high-protein diets are not detrimental to bone but large and long clinical trials are needed to clarify if protein provides benefit on calcium absorption and bone health
Why this rating
The paper highlights conflicting or inconclusive interventional data (isotope tracers) vs. observational data (HR-pQCT).
Source
Exploring Opportunities to Better Characterize the Effects of Dietary Protein on Health across the Lifespan
John W. Carbone et al. · Advances in Nutrition · 2024
DOI 10.1016/j.advnut.2024.100347
narrative_reviewCited 7×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Higher dietary protein intake (1.2-1.6 g/kg/d) during energy restriction preserves lean mass and promotes fat loss more effectively than lower protein intakes.Good
- Higher dietary protein intake (25-30% of daily kcal) improves cardiometabolic health markers, including insulin sensitivity and blood pressure, particularly when combined with energy restriction or specific protein sources like milk protein isolate.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →